is semaglutide fda approved for mash 🎉Exciting news that now (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% semaglutide fda approval mash Semaglutide

Daily dosing needs roughly five to six weeks to reach readable steady state

The RASS trial was a controlled trial involving 223 normotensive patients with type 1 diabetes and normoalbuminuria and who were randomly assigned to receive losartan, enalapril, or placebo (50)

The key distinction is that Wegovy is formulated at a higher dose to achieve the robust weightloss effect that the FDA approved it for, whereas Ozempics dosing is optimized for glycemic control (type-2 diabetes)

Hypertrophic adipocytes undergo phenotypic changes and begin to secrete inflammatory adipokines (bioactive molecules released from an adipocyte) and cytokines (immune signaling molecules involved in inflammation, immunity, and cell communication)

Clinical trials reveal that semaglutide, a GLP-1 receptor agonist, preferentially targets visceral adiposity during weight loss, making it a precision tool for metabolic health rather than appearance alone

Weight reduction: Many people experience meaningful weight loss, largely due to reduced appetite and earlier satiety